These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5355632)

  • 1. [Clinical trial of ornithine alpha ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14(4):Suppl 3:512-5. PubMed ID: 5355632
    [No Abstract]   [Full Text] [Related]  

  • 2. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of alpha ornithine ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our clinical experience with ornithine aspartate].
    Szirmai E
    Minerva Med; 1971 Jun; 62(47):2376-82. PubMed ID: 5087700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Personal experiences in the treatment of internal diseases with ornithine aspartate].
    Perinović M; Robović Z; Grujić M; Ljubojević S
    Med Arh; 1969; 23(3):29-32. PubMed ID: 5200044
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protection of the liver and liver therapy with Hepamerz].
    Heynen U
    Z Allgemeinmed; 1970 Jan; 46(2):87-8. PubMed ID: 5439291
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
    Hunold W
    Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of ornithine-aspartate on the increased GOT activity in bovine serum].
    Sommer H; Unglaub W
    Berl Munch Tierarztl Wochenschr; 1972 Apr; 85(7):123-5. PubMed ID: 5032067
    [No Abstract]   [Full Text] [Related]  

  • 11. [The hepato-protective effect of a combination of amino acids of the Krebs-Henseleit cycle. Clinical and statistical considerations].
    Ruberti A; Mirizio A; Accardo G
    Clin Ter; 1969 Sep; 50(5):397-425. PubMed ID: 5382524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 13. [A controlled trial of ornithine alpha-ketoglutarate in neuro-traumatology].
    Debout J; Salvetti B; Krivosic-Horber R
    Cah Anesthesiol; 1986 Oct; 34(6):501-4. PubMed ID: 3542145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological and biochemical analysis of the action of Ornitaine on the diseased liver].
    Billiottet J
    Clinique (Paris); 1966 Jan; 60(615):67-70. PubMed ID: 4159874
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hepatic comas by ornithine alpha-ketoglutarate].
    Tête R; Paliard P; Vachon A
    Rev Lyon Med; 1966 Apr; 15(8):371-8. PubMed ID: 5942225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of ornithine alpha-ketoglutarate in malnourished cancer patients].
    Filoche B; Lefebvre V; Herlin F
    Med Chir Dig; 1982; 11(3):223-5. PubMed ID: 6808262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral ornithine alpha-ketoglutarate in the prevention of local complications of plastic surgery. Double-blind controlled study of 42 cases].
    Bouchon Y; Merle M
    Ann Chir Plast Esthet; 1984; 29(4):385-8. PubMed ID: 6084450
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intravenous administration of ornithine aspartate to patients with hepatic diseases].
    Schäfer W
    Munch Med Wochenschr; 1968 Oct; 110(43):2521-5. PubMed ID: 5755238
    [No Abstract]   [Full Text] [Related]  

  • 20. L-ornithine alpha-ketoglutarate in HIV infection: effects on muscle, gastrointestinal, and immune functions.
    Karsegard VL; Raguso CA; Genton L; Hirschel B; Pichard C
    Nutrition; 2004 Jun; 20(6):515-20. PubMed ID: 15165613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.